Minerva Neurosciences, Inc.
METHODS OF USE OF CYCLIC AMIDE DERIVATIVES TO TREAT SIGMA RECEPTOR MEDIATED DISORDERS
Last updated:
Abstract:
Disclosed herein are compositions and methods for treating a sigma-2 receptor-mediated condition or disorder, including treating one or more symptoms of a sigma-2 receptor-mediated condition or disorder.
Status:
Application
Type:
Utility
Filling date:
29 Jun 2020
Issue date:
15 Apr 2021